Stanford will rename campus spaces named for David Starr Jordan and relocate statue depicting Louis Agassiz
By Chris Peacock,
Stanford News
| 10. 07. 2020
Stanford will rename campus features named after David Starr Jordan and take actions to provide the public with a more complete view of his complex history, which includes not only his seminal leadership as the university’s founding president but also his parallel leadership in promoting eugenics.
The university will also relocate from the façade of Jordan Hall a statue of Jordan’s mentor, Louis Agassiz.
The decision follows a review conducted this summer by a committee of faculty, staff, students and alumni. The university’s Board of Trustees, acting on a recommendation by President Marc Tessier-Lavigne, approved these steps:
- Removing Jordan’s name from Jordan Hall, current home of the Department of Psychology; Jordan Quad and Jordan Modulars, near Panama Street and Campus Drive West; and Jordan Way in the Stanford Medical Center area;
- Relocating a statue of Agassiz from Jordan Hall to a location where it can be given appropriate context; and
- Developing an active effort to better explain the full range of Jordan’s legacy and contributions, beginning with an informational plaque in Jordan Hall and extending to additional efforts such as...
Related Articles
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...
By Rob Stein, NPR | 07.16.2025
Scientists can protect children from being born with certain devastating genetic disorders by creating "three-parent" babies, according to the results of a landmark study released Wednesday.
British researchers used the experimental technique to help families have eight children who appear...